MYC and glioblastoma: Entinostat (MS275), a class I HDACi targeting HDAC1, HDAC2, and HDAC3, has been shown to suppress FLICE inhibitory protein expression through the myelocytomatosis oncogene (c-Myc) pathway, thereby inducing apoptosis and inhibiting GBM cell growth [124].